English
DOI:
https://doi.org/10.1590/s2175-97902022e20225Palavras-chave:
EnglishResumo
A cationic liposomal gene delivery system comprising DOTAP, DOPE, and cholesterol was prepared and optimized. The results showed that the liposome/DNA (LP/DNA) system had spherical morphology, with a particle size of around 150 nm and zeta potential of approximately 30 mV. Cytotoxicity experiments showed that cells treated with all of the liposome carriers- with the exception of LP1-had more than 80% viability even at a weight ratio of 30. The in vitro transfection efficiency was measured using a Promega™ Luciferase Assay System. Of the tested lipoplexes, LP2/DNA showed the highest cell transfection efficiency (at a weight ratio of 10)-which was similar to or slightly lower than that of Lipofectamine® 2000 in HeLa, A549, and SPC-A1 cell lines. After freeze-drying, the cell transfection efficiency decreased slightly (P>0.05). The cell uptake mechanism study showed that LP/DNA lipoplexes mainly entered cells via clathrin-mediated and caveolin-mediated endocytic pathways. The results confirmed that LP2 has potential for use as an effective gene carrier, and provides experimental evidence to support its further development as a safe and effective gene delivery system.
Downloads
Referências
Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688-1713.
Anchordoquy TJ, Koe GS. Physical stability of nonviral plasmid-based therapeutics. J Pharm Sci. 2000;89(3):289-296.
Cui P, Qi L, Wang Y, Yu R, He Y, Xing L, et al. Dex-Aco coating simultaneously increase the biocompatibility and transfection efficiency of cationic polymeric gene vectors. J Control Release. 2019;303:253-262.
Cui S, Wang B, Zhao Y, Chen H, Ding H, Zhi D, et al. Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells. Biotechnol Lett. 2014;36(1):1-7.
Der Aa MaEMV, Huth US, Hafele SY, Schubert R, Oosting RS, Mastrobattista E, et al. Cellular uptake of cationic Polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 Cells. Pharm Res. 2007;24(8):1590-1598.
Di Tommaso C, Como C, Gurny R, Möller M. Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations. Eur J Pharm Sci . 2010;40(1):38-47.
Ewe A, Panchal O, Pinnapireddy SR, Bakowsky U, Przybylski S, Temme A, et al. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo. Nanomedicine. 2017;13(1):209-218.
Guo X, Huang L. Recent advances in nonviral vectors for gene delivery. Acc Chem Res. 2012;45(7):971-979.
Hattori Y, Tamaki K, Ozaki K-I, Kawano K, Onishi H. Optimized combination of cationic lipids and neutral helper lipids in cationic liposomes for siRNA delivery into the lung by intravenous injection of siRNA lipoplexes. J Drug Deliv Sci Technol. 2019;(52):1042-1050.
Huang Q, Ren J, Ou W, Fu Y, Cai M, Zhang J, et al. Cationic lipids containing cyclen and ammonium moieties as gene delivery vectors. Chem Biol Drug Des. 2012;79(6):879-887.
Jia J, Menglei H, Ning W, Yilin H, Xixi M, Yiyang J, et al. Cholesterol derived cationic lipids as potential non-viral gene delivery vectors and their serum compatibility. Bioorg Med Chem Lett. 2016;26(10):2401-2407.
Jin L, Zeng X, Liu M, Deng Y, He N. Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics. 2014;4(3):240-255.
Kamimura K, Suda T, Zhang G, Liu D. Advances in gene delivery systems. Pharmaceut Med. 2011;25(5):293-306.
Korang-Yeboah M, Gorantla Y, Paulos SA, Sharma P, Chaudhary J, Palaniappan R. Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization. Int J Nanomed. 2015;(10):4763-4781.
Kou L, Sun J, Zhai Y, He Z, The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asi J Pharm Sci . 2013;8(1):1-10.
Li H, Xu S, Quan J, Yung B, Pang J, Zhou C, Cho Y, et al. CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia. Mol Pharm. 2015;12(6):2010-2018.
Lin C, Huang Z, Wen W, Wu A, Wang C, Niu L. Enhancing protein expression in HEK-293 cells by lowering culture temperature. PLoS One. 2015;10(4):e0123562.
Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A. 2010;107(5):1864-1869.
Luu Q-P, Shin J-Y, Kim Y-K, Islam MA, Kang S-K, Cho M-H, et al. High gene transfer by the osmotic polysorbitol-mediated transporter through the selective caveolae endocytic pathway. Mol Pharm . 2012;9(8):2206-2218.
Mochizuki S, Kanegae N, Nishina K, Kamikawa Y, Koiwai K, Masunaga H, et al. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochim Biophys Acta Mol Cell Biol Lipids. 2013;1828(2):412-418.
Morais AR, Alencar Édo N, Xavier Júnior FH, De Oliveira CM, Marcelino HR, Barratt G, et al. Freeze-drying of emulsified systems: A review. Int J Pharm. 2016;503(1-2):102-114.
Nascimento TL, Hillaireau H, Noiray M, Bourgaux C, Arpicco S, Pehauarnaudet G, et al. Supramolecular organization and siRNA binding of hyaluronic acid-coated lipoplexes for targeted delivery to the CD44 receptor. Langmuir. 2015;31(41):11186-11194.
Rasoulianboroujeni M, Kupgan G, Moghadam F, Tahriri M, Boughdachi A, Khoshkenar P, et al. Development of a DNA-liposome complex for gene delivery applications. Mater Sci Eng C Mater Biol Appl. 2017;75:191-197.
Shah M, Bourner L, Ali S, Al-Enazy S, Rytting E. Cytotoxicity of endocytosis and efflux inhibitors in the BeWo cell line. J Pharm Res Int. 2017;17(5):JPRI.34606.
Sheng R, Wang Z, Luo T, Cao A, Sun J, Kinsella JM. Skeleton-controlled pDNA delivery of renewable steroid-based cationic lipids, the endocytosis pathway analysis and intracellular localization. Int J Mol Sci. 2018;19(2):369.
Soema PC, Willems GJ, Jiskoot W, Amorij JP, Kersten GF. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. Eur J Pharm Biopharm. 2015;94:427-435.
Stark B, Pabst G, Prassl R. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure. Eur J Pharm Sci . 2010;41(3-4):546-555.
Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev . 2006;58(14):1532-1555.
Valero L, Alhareth K, Espinoza Romero J, Viricel W, Leblond J, Chissey A, et al. Liposomes as gene delivery vectors for Human Placental Cells. Molecules. 2018;23(5):1085.
Van Deutekom JCT, Van Ommen GB. Advances in Duchenne muscular dystrophy gene therapy. Nature. 2003;4(10):774.
Vitor MT, Bergami-Santos PC, Barbuto JA, De La Torre LG. Cationic liposomes as non-viral vector for RNA delivery in cancer immunotherapy. Recent Pat Drug Deliv Formul. 2013;7(2):99-110.
Wang F, Shen Y, Zhang W, Li M, Wang Y, Zhou D, et al. Efficient, dual-stimuli responsive cytosolic gene delivery using a RGD modified disulfide-linked polyethylenimine functionalized gold nanorod. J Control Release . 2014;196:37-51.
Wang H, Liu W, Sun M, Chen D, Zeng L, Lu L, et al. Inhibitor analysis revealed that clathrin-mediated endocytosis is involed in cellular entry of type III grass carp reovirus. Virol J. 2018;15(1):92.
Wieber A, Selzer T, Kreuter J. Physico-chemical characterisation of cationic DOTAP liposomes as drug delivery system for a hydrophilic decapeptide before and after freeze-drying. Eur J Pharm Biopharm . 2012;80(2):358-367.
Zhang Y, Li H, Sun J, Gao J, Liu W, Li B, et al. DC-Chol/ DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm . 2010;390(2):198-207.
Zhang Y, Zhou C, Kwak KJ, Wang X, Yung BC, Lee LJ, et al. Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core. Pharm Res . 2012;29(6):1627-1636.
Downloads
Publicado
Edição
Seção
Licença
Direitos autorais (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
